This article was originally published in The Rose Sheet
Executive SummaryCenter for Food Safety & Applied Nutrition would receive $446.7 mil. in funding under the FY 2004 Agriculture appropriations bill, passed by the House July 13. Center for Drug Evaluation & Research is allotted $499 mil., with an additional $500,000 to come from funding removed from the Office of the Commissioner under an amendment introduced by Rep. Maurice Hinchey (D-N.Y.). Amendment is intended to cut the budget of the FDA Chief Counsel's office while enhancing CDER's Division of Drug Marketing, Advertising & Communications. Hinchey has accused FDA Chief Counsel Daniel Troy of improperly intervening in state civil cases against drug and device manufacturers...
You may also be interested in...
The company maintains that its products are safe, but plaintiffs in proposed class actions allege it has knowingly put consumers at risk of hair loss and other injuries. DevaCurl’s troubles escalated quickly after a former brand ambassador went viral with a 31 January video urging consumers to stop using DevaCurl products and adopt safer alternatives.
To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.
Glenmark can sell its partnered generic rival to GSK’s Seretide Accuhaler dry powder inhaler in certain European markets following a settlement with the UK company. The Indian firm has also shelved divestment plans for its API business, at least for now.